Clinical Trials Browser

Neuroblastoma × 3-fluorobenzylguanidine × 90 days × Clear all

NCT04724369 2026-04-03

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Phase 3 Active not recruiting

Neuroblastoma